Iohexol
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB01362 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | insomnia (disease) | KG + DL |
| 2 | anxiety | KG + DL |
| 3 | rheumatoid arthritis | KG + DL |
| 4 | antithrombin deficiency type 2 | KG + DL |
| 5 | factor 5 excess with spontaneous thrombosis | KG + DL |
| 6 | sleep disorder, initiating and maintaining sleep | KG + DL |
| 7 | heparin cofactor 2 deficiency | KG + DL |
| 8 | fibromyalgia | KG + DL |
| 9 | conjunctivitis | KG + DL |
| 10 | tendinitis | KG + DL |
| 11 | anxiety disorder | KG + DL |
| 12 | myositis fibrosa | KG + DL |
| 13 | idiopathic granulomatous myositis | KG + DL |
| 14 | colobomatous microphthalmia-rhizomelic dysplasia syndrome | KG + DL |
| 15 | migraine with or without aura, susceptibility to | KG + DL |
| 16 | myofascial pain syndrome | KG + DL |
| 17 | brachydactyly-syndactyly syndrome | KG + DL |
| 18 | agoraphobia | KG + DL |
| 19 | alcohol withdrawal delirium | KG + DL |
| 20 | benign paroxysmal torticollis of infancy | KG + DL |
| 21 | inclusion body myositis | KG + DL |
| 22 | migraine disorder | KG + DL |
| 23 | irritable bowel syndrome | KG + DL |
| 24 | thrombophilia | KG + DL |
| 25 | migraine with brainstem aura | KG + DL |
| 26 | antidepressant type abuse | KG + DL |
| 27 | hallucinogen abuse | KG + DL |
| 28 | barbiturate abuse | KG + DL |
| 29 | neuralgia | KG + DL |
| 30 | atrophoderma vermiculata | KG + DL |
| 31 | peripheral arterial disease | KG + DL |
| 32 | sciatic neuropathy | KG + DL |
| 33 | ulerythema ophryogenesis | KG + DL |
| 34 | acute encephalopathy with biphasic seizures and late reduced diffusion | KG + DL |
| 35 | amenorrhea (disease) | KG + DL |
| 36 | neurocirculatory asthenia | KG + DL |
| 37 | thrombotic disease | KG + DL |
| 38 | cauda equina syndrome | KG + DL |
| 39 | strongyloidiasis | KG + DL |
| 40 | peripheral vascular disease | KG + DL |
| 41 | ischemic disease | KG + DL |
| 42 | angiodysplasia | KG + DL |
| 43 | uveitis | KG + DL |
| 44 | venous thromboembolism | KG + DL |
| 45 | fibrocartilaginous embolism | KG + DL |
| 46 | non-inflammatory vasculopathy | KG + DL |
| 47 | corpus callosum, agenesis of | KG + DL |
| 48 | leprosy | KG + DL |
| 49 | vascular ectasia | KG + DL |
| 50 | congenital renal artery stenosis | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.